Altimmune, Inc. Quarterly Other Assets, Noncurrent in USD from Q4 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Altimmune, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2011 to Q3 2024.
  • Altimmune, Inc. Other Assets, Noncurrent for the quarter ending September 30, 2024 was $1.66M, a 290% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $1.66M +$1.23M +290% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $1.68M +$1.19M +247% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $299K -$247K -45.2% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $363K -$252K -41% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $425K -$257K -37.7% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $483K -$264K -35.3% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $546K -$265K -32.7% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $615K -$257K -29.5% Dec 31, 2022 10-K 2024-03-27
Q3 2022 $682K -$250K -26.8% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $747K -$182K -19.6% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $811K +$696K +603% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $872K -$105K -10.8% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $932K +$845K +969% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $929K +$828K +820% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 $115K +$536 +0.47% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $977K +$849K +660% Dec 31, 2020 10-K 2022-03-15
Q3 2020 $87.2K -$55.1K -38.7% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $101K -$55.1K -35.3% Jun 30, 2020 10-Q 2020-08-11
Q1 2020 $115K -$55.1K -32.5% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 $129K -$55.1K -30% Dec 31, 2019 10-K 2021-02-25
Q3 2019 $142K -$1.01M -87.6% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 $156K -$255K -62% Jun 30, 2019 10-Q 2019-08-13
Q1 2019 $170K -$55.2K -24.5% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 $184K -$55.2K -23.1% Dec 31, 2018 10-K 2020-03-27
Q3 2018 $1.15M +$1.13M +5065% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 $411K +$389K +1749% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 $225K Mar 31, 2018 10-Q 2018-05-15
Q4 2017 $239K +$217K +974% Dec 31, 2017 10-K 2019-04-01
Q3 2017 $22.2K +$22.2K Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $22.2K +$22.2K Jun 30, 2017 10-Q 2017-08-14
Q4 2016 $22.2K -$31.1K -58.3% Dec 31, 2016 10-K 2018-04-02
Q3 2016 $0 -$53.4K -100% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 $0 -$53.4K -100% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 $53.4K $0 0% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 $53.4K $0 0% Dec 31, 2015 10-K 2017-03-14
Q3 2015 $53.4K $0 0% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 $53.4K -$1.65K -3% Jun 30, 2015 10-Q 2015-08-05
Q1 2015 $53.4K -$5.75K -9.72% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 $53.4K -$12.3K -18.7% Dec 31, 2014 10-K 2016-03-11
Q3 2014 $53.4K -$21.2K -28.4% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 $55K -$30.9K -35.9% Jun 30, 2014 10-Q 2014-08-05
Q1 2014 $59.1K -$40.4K -40.6% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 $65.7K -$47.5K -42% Dec 31, 2013 10-K 2015-03-11
Q3 2013 $74.6K -$56.1K -42.9% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 $85.9K -$64.6K -42.9% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 $99.6K -$74.9K -42.9% Mar 31, 2013 10-Q 2013-05-08
Q4 2012 $113K +$59.7K +112% Dec 31, 2012 10-K 2014-03-11
Q3 2012 $131K Sep 30, 2012 10-Q 2012-11-06
Q2 2012 $150K Jun 30, 2012 10-Q 2012-08-07
Q1 2012 $175K Mar 31, 2012 10-Q 2012-05-10
Q4 2011 $53.4K Dec 31, 2011 10-K 2013-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.